AbbVie
Duplicate source posts collapse into one event. Only direct subject-company stories are included in this public hub.
Piper Sandler increased its price target on AbbVie to $303 from $298. The new target implies a slight upside from the prior level. No additional details were provided.
Explore the exact intelligence modules available on every supported company page.